Decreased spexin levels in patients with type 1 and type 2 diabetes A Karaca, F Bakar-Ates, N Ersoz-Gulcelik Medical Principles and Practice 27 (6), 549-554, 2019 | 60 | 2019 |
Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents Z Kilic-Kurt, N Ozmen, F Bakar-Ates Bioorganic Chemistry 101, 104028, 2020 | 41 | 2020 |
Effect of semi-rapid maxillary expansion in children with obstructive sleep apnea syndrome: 5-month follow-up study S Hoxha, E Kaya-Sezginer, F Bakar-Ates, O Köktürk, U Toygar-Memikoğlu Sleep and Breathing 22, 1053-1061, 2018 | 37 | 2018 |
Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage F Bakar-Ates, E Ozkan, CT Sengel-Turk International Journal of Pharmaceutics 586, 119565, 2020 | 30 | 2020 |
Antioxidant Activity and Phytochemical Analysis of Alchemilla Persica Rothm. B Ergene, Ö Bahadır Açıkara, F Bakar, G Saltan, S Nebioğlu J.Fac.Pharm.Ankara 39 (2), 145-154, 2010 | 28 | 2010 |
Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells M Ergul, F Bakar-Ates Toxicology in Vitro 73, 105138, 2021 | 27 | 2021 |
Comparative evaluation of nimesulide-loaded nanoparticles for anticancer activity against breast cancer cells CT Sengel-Turk, C Hascicek, F Bakar, E Simsek Aaps PharmSciTech 18, 393-403, 2017 | 26 | 2017 |
Ferroptosis: a trusted ally in combating drug resistance in cancer E Ozkan, F Bakar-Ates Current Medicinal Chemistry 29 (1), 41-55, 2022 | 25 | 2022 |
Fulvestrant-loaded polymer-based nanoparticles for local drug delivery: Preparation and in vitro characterization C Hasçiçek, CT Sengel-Turk, M Gumustas, AS Ozkan, F Bakar, ... Journal of Drug Delivery Science and Technology 40, 73-82, 2017 | 21 | 2017 |
Anticancer effect of Ferulago mughlea Peşmen (Apiaceae) on cancer cell proliferation B Filiz, K Songül, D Bostanlık, F Gül, KC Sibel Iranian Journal of Pharmaceutical Research: IJPR 15 (3), 501, 2016 | 21 | 2016 |
Design, synthesis and in vitro apoptotic mechanism of novel pyrrolopyrimidine derivatives Z Kilic-Kurt, F Bakar-Ates, Y Aka, O Kutuk Bioorganic Chemistry 83, 511-519, 2019 | 20 | 2019 |
Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus A Amanova, Z Kendi Celebi, F Bakar, MG Caglayan, K Keven Clinical transplantation 28 (10), 1177-1183, 2014 | 20 | 2014 |
RO3280: a novel PLK1 inhibitor, suppressed the proliferation of MCF-7 breast cancer cells through the induction of cell cycle arrest at G2/M point M Ergul, F Bakar-Ates Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 18 | 2019 |
The combined treatment of brassinin and imatinib synergistically downregulated the expression of MMP‐9 in SW480 colon cancer cells F Bakar‐Ates, E Ozkan Phytotherapy Research 33 (2), 397-402, 2019 | 18 | 2019 |
Cucurbitacin B enhances the anticancer effect of imatinib mesylate through inhibition of MMP-2 expression in MCF-7 and SW480 tumor cell lines F Bakar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 18 | 2016 |
Antioxidant activity and phytochemical screening of some Asteraceae plants F Bakar, ÖB Acikara, B Ergene, S Nebioglu, GS Citoglu Turk. J. Pharm. Sci 12, 123-132, 2015 | 18 | 2015 |
Synthesis of new indole-2-carboxamide and 3-acetamide derivatives and evaluation their antioxidant properties S Ölgen, F Bakar, S Aydin, D Nebioğlu, S Nebioğlu Journal of enzyme inhibition and medicinal chemistry 28 (1), 58-64, 2013 | 18 | 2013 |
Design, characterization and evaluation of cucurbitacin B-loaded core–shell-type hybrid nano-sized particles using DoE approach CT Sengel-Turk, N Ozmen, F Bakar-Ates Polymer Bulletin 78 (6), 3327-3351, 2021 | 17 | 2021 |
Gold nanoparticle-lignan complexes inhibited MCF-7 cell proliferation in vitro: a novel conjugation for cancer therapy F Bakar, M G Caglayan, F Onur, S Nebioglu, I M Palabiyik Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 16 | 2015 |
A specific inhibitor of polo-like kinase 1, GSK461364A, suppresses proliferation of Raji Burkitt's lymphoma cells through mediating cell cycle arrest, DNA damage, and apoptosis M Ergul, F Bakar-Ates Chemico-biological interactions 332, 109288, 2020 | 15 | 2020 |